This suggests that the interaction between MAdCAM-1 and α4β7 is closely related to the recruitment of lymphocytes to the intestine in chronic inflammatory diseases, and blocking their binding could be a relevant therapeutic target for inflammatory bowel disease patients [54]. This evidence concerns the gene MADCAM1 and inflammatory bowel disease.